FDA updates Uganda travel-screening advice for U.S. blood establishments
FDA says blood establishments may stop asking donors about residence in or travel to Uganda under its Ebola-related screening recommendations.
What the record says
The October 22 update says the agency’s decision follows improvement in Uganda’s Ebola situation. It modifies the country-specific screening advice issued in June. FDA says it will continue monitoring conditions with CDC and update recommendations as needed.
Source details and supporting locations.
Practical next step
Blood establishments should consult the complete current FDA communication and applicable donor-eligibility guidance before changing procedures.
Limits and what is not established
This is a specific change to Uganda-related questions. It does not remove all donor-eligibility requirements or declare every country free of Ebola risk.
Sources checked October 24, 2026. Later notices may change instructions or arrangements.
Original sources
U.S. Food and Drug Administration: original information